Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Quest Pharmatech Inc
V.QPT
Alternate Symbol(s):
QPTFF
Healthcare
Biotechnology
Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest...
Inc., which is a biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest Inc.’s technology platform includes a panel of tumor antigen specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent, which is developing antibody-based immunotherapeutic products for cancer in the Greater China territory.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:QPT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(309)
•••
G1945V
X
Comment by
G1945V
on Sep 23, 2023 8:05am
RE:RE:RE:Interesting
OPPS! I missed the first tranche of $22,291,000 was paid out immediately assuming that being May 2023?? So where is our 42.5 % of the $22,291,000 interest in OncoQuest sitting
...more
(309)
•••
G1945V
X
Comment by
G1945V
on Sep 23, 2023 7:42am
RE:RE:Interesting
"The cash is receivable in 3 tranches (immediately – 21.6 billion KRW ($22,291,000), end of December 2023 – 25.9 billion KRW ($26,728,600) and end of June 2024 – 30.0 billion KRW ($30,959,800
...more
GMV Minerals Receives Helicopter-Borne High Resolution Magnetic and Radiometric Survey Results
posted Nov 29, 2023 9:00am by
GMV Minerals Inc
-
|
The Company is pleased to announce that it has received the completed geophysical surveys from Precision GeoSurveys Inc. of Langley, British Columbia on its Daisy Creek project in Lander County, Nevada. Ian Klassen, CEO remarked, "We are very pleased with the results of this survey. We know that high-grade lithium assays (up to 20,000 ppm Li) came from a uranium exploration program, and that the ...read more
(309)
•••
G1945V
X
Comment by
G1945V
on Sep 23, 2023 7:18am
RE:RE:Interesting
The original deal was for U.S. $ 300 million in a combination of Dual common stock and Dual perpetual convertible bonds. Why has this dwindled down to only $79,979,000 in cash and $66,700,000 in bonds
...more
(45)
•••
ARIMA11
X
Comment by
ARIMA11
on Sep 22, 2023 3:17pm
RE:Interesting
i) Correction: It Iooks like OncoQuest got some... cash: In return, OncoQuest received US$125 million of OQP Korea bonds convertible into OQP Korea shares, US$8.4 million in cash, and an OQP Korea
...more
(309)
•••
G1945V
X
Comment by
G1945V
on Sep 20, 2023 6:18am
RE:Interesting
Hoping that the largest shareholder of QPT, "Shenzhen Hepalink Pharmaceutical Group Co. Ltd " with a 15% ownership will jump in and stir the ship for Madiyalakan because he sucks at
...more
(45)
•••
ARIMA11
X
Post by
ARIMA11
on Sep 18, 2023 3:40pm
Interesting
https://ceo.ca/@newswire/quest-pharmatech-provides-corporate-update-e1c0d The assets transfer could be a good "how not to" case for business schools. Three years plus after the sale not a
...more
(45)
•••
ARIMA11
X
Post by
ARIMA11
on Sep 05, 2023 1:31pm
Interesting
CEO is buying at the open market... https://ceo.ca/qpt?23cb45f8a96a
(309)
•••
G1945V
X
Post by
G1945V
on Jul 13, 2023 11:40am
Annual general meeting today July 13, 2023
Meeting time 11 AM Edmonton time: 1 PM Toronto Time (EST) Shareholders can also participate in the meeting via teleconference. Does anyone know how we connect via teleconference? G1945V
(1716)
•••
lscfa
X
Post by
lscfa
on Jul 11, 2023 1:23am
Patent granted
https://www.newswire.ca/news-releases/quest-pharmatech-provides-product-development-update-881782265.html
(309)
•••
G1945V
X
Comment by
G1945V
on Jun 21, 2023 7:44am
RE:RE:New Press Release - Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.
If things go according to Hoyle financially in accordance with the latest annual financials, the book value share price calculates to approximately 50 cents Cdn. The current market value share price
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 09, 2023 5:00pm
New Press Release - Quest PharmaTech Provides Corporate Update
TSX Venture: QPT EDMONTON, AB, June 9, 2023 /CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") provided the following corporate update today.Grant of Stock OptionsQuest announces the granting of 1,250,000 stock options to 2 Officers, at an exercise price of $0.10 per common...
read article.
(309)
•••
G1945V
X
Comment by
G1945V
on Jun 08, 2023 7:18am
RE:New Press Release - Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.
So are we to assume that the cash payments (payable in 3 tranches) of the June 2, 2023 news release do not apply? "If the transaction is completed as proposed, the Company would receive
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 07, 2023 7:52am
New Press Release - Canadian Investment Regulatory Organization Trade Resumption - QPT
VANCOUVER, BC, June 7, 2023 /CNW/ - Trading resumes in:Company: Quest PharmaTech Inc.TSX-Venture Symbol: QPT All Issues: YesResumption (ET): 9:30 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 06, 2023 5:16pm
New Press Release - Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.
TSX Venture: QPTEDMONTON, AB, June 6, 2023 /CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company"), at the request of the TSX Venture Exchange, is providing additional information to clarify certain information contained in the Company's news release dated June 2, 2023 announcing the...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 06, 2023 8:03am
New Press Release - Canadian Investment Regulatory Organization Trading Halt - QPT
VANCOUVER, BC, June 6, 2023 /CNW/ - The following issues have been halted by CIROCompany: Quest PharmaTech Inc.TSX-Venture Symbol: QPTAll Issues: YesReason: At the request of the Listing ExchangeHalt Time (ET): 7:45 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Pulsar Helium to Present and Host Open Q&A at the Emerging Growth Conference Dec. 7 – Register Now
AI Beyond Hype: Real-world Applications and Possibilities
Want to know which Canadian silver exchange traded funds on the Toronto Stock Exchange are the best?
Stunning Drill Results at Historic Copper Mine in Ontario with 14.8% Copper over 2.45 Metres